Genprex Inc is a biotechnology company focused on developing innovative gene therapy treatments for cancer and diabetes. Their primary aim is to enhance the efficacy of existing therapies and improve patient outcomes through the use of their proprietary Oncoprex immunogene therapy, which targets various types of tumors. The company is dedicated to advancing its promising treatments through clinical trials and aims to address significant unmet medical needs in oncology. With a strong emphasis on research and development, Genprex seeks to create transformative therapies that can benefit patients and improve their quality of life. Read More
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
The regular session of the US market on Wednesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
